share_log

BioVie | DEF 14A: Definitive information statements

BioVie | DEF 14A: Definitive information statements

BioVie | DEF 14A：股东委托书决议
美股SEC公告 ·  2024/09/28 05:05

Moomoo AI 已提取核心信息

BioVie Inc., a Nevada corporation, announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its upcoming annual meeting of stockholders scheduled for November 7, 2024. The virtual meeting format will prevent in-person attendance but allows stockholders to participate online. The agenda includes the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year 2025, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan to increase the number of shares authorized for issuance. The board has fixed September 30, 2024, as the record date, meaning only stockholders of record on this date are entitled to vote. The proxy materials, including the 2024 Annual Report and proxy card, will be available online and are being mailed to stockholders around October 9, 2024.
BioVie Inc., a Nevada corporation, announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its upcoming annual meeting of stockholders scheduled for November 7, 2024. The virtual meeting format will prevent in-person attendance but allows stockholders to participate online. The agenda includes the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year 2025, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan to increase the number of shares authorized for issuance. The board has fixed September 30, 2024, as the record date, meaning only stockholders of record on this date are entitled to vote. The proxy materials, including the 2024 Annual Report and proxy card, will be available online and are being mailed to stockholders around October 9, 2024.
BioVie Inc.，一家内华达州公司，宣布向美国证券交易委员会（SEC）提交一份明确的代理人声明（DEF 14A），用于即将于2024年11月7日举行的股东年会。虚拟会议形式将阻止现场出席，但允许股东在线参与。议程包括选举六名董事，核准EisnerAmper LLP为2025财政年度的独立注册会计师事务所，对执行薪酬进行表决，以及批准2019年全权股权激励计划修正案，以增加发行授权股份数量。董事会已确定2024年9月30日为记录日期，意味着仅有截至该日期的股东有权投票。代理材料，包括2024年年度报告和代理投票卡，将可在线获取，并将于2024年10月9日左右邮寄给股东。
BioVie Inc.，一家内华达州公司，宣布向美国证券交易委员会（SEC）提交一份明确的代理人声明（DEF 14A），用于即将于2024年11月7日举行的股东年会。虚拟会议形式将阻止现场出席，但允许股东在线参与。议程包括选举六名董事，核准EisnerAmper LLP为2025财政年度的独立注册会计师事务所，对执行薪酬进行表决，以及批准2019年全权股权激励计划修正案，以增加发行授权股份数量。董事会已确定2024年9月30日为记录日期，意味着仅有截至该日期的股东有权投票。代理材料，包括2024年年度报告和代理投票卡，将可在线获取，并将于2024年10月9日左右邮寄给股东。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    ImmunoPrecise Antibodies
    IPA
    -- 0.701
    Nutriband
    NTRB
    -- 6.879
    Seres Therapeutics
    MCRB
    -- 0.929
    Rein Therapeutics
    RNTX
    -- 2.420
    Absci Corp
    ABSI
    -- 3.990
    解锁完整榜单
    热门中概股
    追踪最热门的中概股实时资讯。
    热门讨论
    中美谈话新契机，通胀不再？
    🎙️讨论： 1. 你认为特朗普上台后，对华政策将如何影响中国资产？ 2. 美股市场通胀风险下降，有哪些利好板块？ 展开
    中国将在未来一年采取"适度宽松"的货币政策，这是自2011年以来的首次转向宽松。